Deltex-1 Activators comprise a range of chemical compounds that indirectly influence the functional activity of Deltex-1 through various interconnected signaling pathways. For example, Retinoic Acid and Dibenzazepine modulate the Notch signaling pathway, a key pathway in which Deltex-1 is involved. Retinoic Acid does this by altering gene expression that includes components of the Notch pathway, while Dibenzazepine inhibits the pathway at the receptor level, resulting in an indirect but significant activation of Deltex-1. Similarly, LY411575 and Cyclopamine impact Deltex-1 activity through the γ-secretase complex and the Hedgehog pathway, respectively. LY411575 achieves this by inhibiting the cleavage of Notch receptors, enhancing the reliance on Deltex-1 for signal transduction, while Cyclopamine alters signaling dynamics in the Hedgehog pathway, thus shifting the balance towards Notch signaling where Deltex-1 is active.
Continuing this theme, compounds like Curcumin, Staurosporine, PD98059, Rapamycin, SB431542, U0126, MG132, and Ionomycin each play a unique role in modulating pathways that ultimately enhance Deltex-1 activity. Curcumin's modulation of NF-κB pathway activity, Staurosporine's inhibition of kinases, and PD98059's influence on the ERK pathway all indirectly activate Deltex-1 by altering the signaling landscape in which it operates. Rapamycin and SB431542, through their action on mTOR and TGF-β receptor pathways respectively, affect cellular processes interconnected with Deltex-1 signaling. U0126's role in dampening the MAPK pathway and MG132's of proteasomal degradation of key proteins further underscore the complex interplay of cellular signaling in enhancing Deltex-1's functional activity. Lastly, Ionomycin elevates intracellular calcium levels, which is crucial in Deltex-1 related signaling, especially in the context of immune cell function. Collectively, these activators, through their targeted modulation of various biochemical pathways, facilitate the enhancement of Deltex-1 mediated functions without the need for upregulating its expression or direct activation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid enhances Deltex-1 activity by modulating the Notch signaling pathway. Deltex-1, as a regulator in this pathway, is indirectly activated when Retinoic Acid binds to its receptors, affecting gene expression that includes components of the Notch pathway. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin enhances Deltex-1 function by modulating NF-κB pathway activity. This modulation indirectly activates Deltex-1 due to its involvement in pathways interconnected with NF-κB signaling, thereby influencing Deltex-1 mediated processes. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Cyclopamine, a Hedgehog pathway inhibitor, indirectly activates Deltex-1 by altering signaling dynamics, as Deltex-1 is involved in cross-talk between the Hedgehog and Notch pathways. This shifts the balance towards Notch signaling, enhancing Deltex-1 activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine, a broad-spectrum kinase inhibitor, enhances Deltex-1 activity by inhibiting kinases that negatively regulate pathways in which Deltex-1 is involved, thus indirectly promoting Deltex-1 mediated signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, an ERK pathway inhibitor, indirectly activates Deltex-1 by altering the downstream signaling balance. This shifts cellular signaling in favor of pathways where Deltex-1 plays a regulatory role. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, an mTOR inhibitor, enhances Deltex-1 activity indirectly by modifying cellular growth and survival pathways, which intersect with Deltex-1 mediated signaling pathways. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542, an inhibitor of the TGF-β receptor, indirectly activates Deltex-1 by impacting signaling pathways that are linked to Deltex-1 function, particularly in developmental processes. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132, a proteasome inhibitor, indirectly activates Deltex-1 by preventing the degradation of proteins involved in signaling pathways where Deltex-1 is a critical component, thus enhancing its functional activity. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin, a calcium ionophore, enhances Deltex-1 activity by increasing intracellular calcium levels, which indirectly influences signaling pathways involving Deltex-1, particularly in immune cell function. | ||||||